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Abstract: Presently, laboratories typically perform urine drug testing with collected urine 
specimens using the dilute and shoot extraction technique. While the dilute and shoot 
technique is a functional means of evaluation for drugs, the development of Volumetric 
Absorptive Microsampling (VAMS) may improve the process of drug testing urine 
samples. This research compared urine analysis using dilute and shoot extraction to that 
of dried VAMS tips for drugs using liquid chromatography – tandem mass spectrometry 
(LC-MS/MS). Most drugs included in the panel were from the benzodiazepine and opioid 
class. The first element of evaluation was the ability to recover glucuronides. A 
hydrolysis method was devised that extracted the tips with methanol, followed by dry 
down and resuspension in enzyme and buffer, allowing for glucuronide conversion to 
parent drug and subsequent analysis.  Following the development of the method, it was 
applied to anonymized specimens and the results were compared with a clinically 
validated dilute and shoot assay.  It was determined that the techniques provided 
qualitatively similar results, suggesting that with appropriate validation, the VAMS 
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Pharmacies in the United States filled over 4 million prescription medications in 2016.1 
Painkillers, antidepressants, and lipid-lowering agents accounted for the majority of prescribed 
therapeutic medications.2 While there are individuals that take their medication as prescribed, 
others misuse their prescription, so prescription compliance monitoring is necessary. This misuse 
can come in various forms, such as by taking a dose higher or lower than prescribed. Another 
option is taking the medication with additional substances when directed not to, such as alcohol. 
Other individuals may decide not to take the prescription altogether, potentially giving away or 
selling the medication to other people. To ensure patients are taking their prescriptions as directed 
many physicians and work environments require some form of drug testing, typically urine drug 
testing.  
Urine drug testing has traditionally been performed by using an aliquot of wet urine in a 
technique termed dilute and shoot (DS), with analysis performed using liquid chromatography-
mass spectrometry (LC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). 
DS has gained popularity primarily due to its ease of use, where an aliquot of urine is diluted 
before being “shot,” or injected, onto the instrument. There are slight variations in the DS 
technique, where some facilities only dilute the sample before injecting it onto the instrument,
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while other laboratories prefer to treat the sample with β-glucuronidase to cleave off glucuronides 
that may be present in the urine to make the method more sensitive to parent drug.  
Volumetric absorptive microsampling (VAMS) is an alternative means of collecting 
samples for analysis. While research has been conducted using VAMS, the majority of studies 
have focused on blood and plasma. At the time of conducting this particular study, there was one 
published article using VAMS with urine samples, completed by Mercolini et al.3 VAMS tips are 
adapted swabs that absorb a specific amount of sample fluid and are then allowed to dry at room 
temperature, which has several advantages over wet specimens. First, the size of the VAMS tips 
is significantly smaller than that of a urine specimen cup. In fact, a box of 96 tips takes up a little 
more counter space than that of a 3 × 5-in notecard, while that same amount of space fits only 
about 4 (2 × 2) specimen cups. Additionally, wet urine samples need to be stored in a refrigerator 
or freezer to prevent degradation, and because specimen cups take up more space, it can be 
challenging to find adequate cold storage space for them. Care must be taken when transporting 
wet samples to ensure they remain cold and do not spill. On the other hand, dry urine samples do 
not have these problems, since the drug residues are dried on the sorbent and are no longer 
subject to enzymatic degradation in transport. Therefore, transportation would be much easier and 
cheaper with dry VAMS samples, as opposed to wet samples. 
The purpose of this study was to determine if dried urine drug testing yields the same 
results as that of wet urine drug testing, when technique specific sample preparation methods are 
performed and followed by sample analysis using LC-MS/MS. Samples were prepared and 
analyzed at Oklahoma State University – Clinical Laboratory Services (OSU-CLS) in Tulsa, OK. 
The technique performed on dry urine samples was extraction in methanol, with subsequent dry-
down followed by reconstitution with hydrolysis enzyme, while wet urine samples were treated 
with the clinically validated DS technique employed by the OSU-CLS facility.  
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Once the wet and dry urine samples were drug tested using LC-MS/MS, the data was 
analyzed so that the following research questions could be evaluated: 1) Is there a difference in 
glucuronide efficiency based on using wet or dry urine samples? 2) In unknown samples, will wet 
and dry urine samples identify the same drugs? Answers to these questions will allow laboratories 
to determine if the transition from wet urine samples to dry urine samples for drug testing would 









Medications have become a common part of society. Allergy sufferers may use over-the-
counter medications or for more severe allergies obtain a prescription from their doctor. Anxiety 
sufferers are prescribed sedatives that provide calming effects needed to carry on with daily 
activities. After recovering from surgery, patients may be prescribed pain killers. Even when 
medications are obtained legally there is still a chance the medications may be misused. Over-the-
counter medicines containing amphetamine and ephedrine are now monitored because 
amphetamine and ephedrine are the precursors in the production of methamphetamine. 
Additionally, some individuals may abuse medications by taking them with the intention of 
getting high. 
Drug tests are conducted to ensure an individual is taking legal and prescribed 
medications. Urine has become the most common bodily fluid used for analysis due to ease of 
collection.4 Liquid chromatography- tandem mass spectrometry (LC-MS/MS) provides a 
sensitive and specific means of qualifying and quantifying drugs and drug metabolites in urine 
samples.5 Dilute and shoot (DS) is the preparation technique typically used for LC-MS/MS drug 
urine analysis. To perform DS, an analyst first receives a specimen cup of the patient’s urine. A 
portion of the urine sample and the internal standard are added together, diluting the sample. 
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Rather than transporting and receiving bulky, wet urine samples in specimen cups, volumetric 
absorptive microsampling (VAMS) tips could be used. These tips are manufactured to absorb a 
fixed volume of fluid. Once allowed to dry, the tips can easily be transported and take up far less 
space than specimen cups.  
2.2 Background 
2.2.1 History of drugs in panel 
Drugs, of the legal or illegal variety, have been used by individuals for centuries.6 
America, in particular, has had an ongoing problem with drug use since the introduction of 
cocaine, heroin, and morphine in the 1800s.6 In 1814, 6 classes of drugs distinguished by their 
toxic effects were documented by M. J. B. Orfila.7 Orfila grouped drugs into the following 
classes: amphetamine-like stimulants, barbiturates, benzodiazepines, opioids, illicit, and other.8 
New regulations in the middle of the 20th century aided in a significant decline in drug abuse, the 
1960s featured a revival of drugs that were now more accessible: amphetamines, hallucinogens, 
and marijuana.6 As the years have progressed, new drugs have entered the market, by legal means 
or otherwise.  
Opioids are drugs derived from opium poppy or commercially manufactured with pain 
relief characteristics.9 Certain opioids are legal through prescriptions; however, other opioids, 
such as heroin, have no legal therapeutic use. A 2016 report by the American Society of 
Addiction Medicine regarding opioids cited drug overdoses as “the leading cause of accidental 
deaths in the US” for 2015.10 Prescription pain killers accounted for 20,101 deaths, with heroin-
related overdoses totaling 12,990.4  
Benzodiazepines are central nervous system depressants prescribed for the treatment of 
anxiety, muscle relaxation, obsessive-compulsive disorder, and more.11 Bachhuber et al. reviewed 
the change in benzodiazepine prescriptions and overdoses resulting in death, finding that from 
1996 to 2013 the rate of benzodiazepine overdose mortalities increased at a faster rate than that of 
benzodiazepine prescriptions being filled.12 
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Cocaine became a Schedule II drug in 1970 because while cocaine had medical value, 
there was a concern for abuse.13,14 Reviewing the statistics of national overdose deaths it is 
evident there was cause to be concerned about cocaine’s potential for abuse, with nearly 7,000 
deaths in 2015.15 Benzoylecgonine is known to be a primary metabolite of cocaine when excreted 
from the body. 14  
Gabapentin was originally prescribed as a treatment for seizure disorders. However, 
gabapentin is now also prescribed to treat drug addiction due to gabapentin’s neurological 
effects.16 From 2008 to 2011 there was a “nearly five times” increase in emergency room visits 
resulting from the “misuse or abuse of gabapentin” in metropolitan areas.17 
Tetrahydrocannabinol (THC) is a type of cannabinoid that is the primary active 
ingredient in the Cannabis plant, which may also be referred to as marijuana, weed, pot, Mary 
Jane, and dozens of other names. At the time of research, 29 states and the District of Columbia 
have laws legalizing the use of THC.18 The Federal government has designated THC as a 
schedule I substance with no medicinal value, and Oklahoma, the state in which this research 
study was conducted, currently considers THC to be an illegal substance. 
2.2.2 Urine drug testing purposes 
Drug testing may be conducted in a variety of fashions. The type of test used is 
determined by the substance and timeframe of interest. Breath tests are useful for evaluating the 
amount of alcohol in an individual’s system at the specific time they are blowing into the 
breathalyzer. Blood samples, which must be collected by a licensed phlebotomist, provide results 
of what is in an individual’s system at the time the sample is drawn and can identify a variety of 
substances. Urine samples can easily be collected with a specimen cup and a restroom. Due to 
known metabolic pathways and elimination rates of medications, most urine samples provide a 2- 
to 3-day history of drug usage.19 As a result of the ease of sample collection, urine is often the 
body fluid of choice for drug testing. 
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Urine drug tests are conducted for various reasons. Pain management clinics require 
testing for prescription compliance, or to ensure the client is taking the prescription as directed 
and that any previously unreported substances are not interfering with the efficacy of the 
prescribed medication.20 In 2015, it was reported that upwards to 75% of patients in pain 
management programs were noncompliant with the proper usage of their prescription; 11% of 
individuals in these programs were positive for one or more illegal substance.5 Some pain 
management clinics have a clause noting that if the individual is found to be taking illegal 
substances or substances not prescribed, the patient may be dismissed from the program.  
Pharmaceutical and clinical trials require testing. As part of the trials it is important to 
know and understand how and the rate at which the body metabolizes xenobiotics. Certain trials 
may also account for multiple medications being taken simultaneously. In these instances, 
potential drug-drug interactions must be observed and potentially monitored. 
Many work environments have begun to impose a “drug free workplace” policy. 
Workplace drug testing is conducted to ensure that employees are unimpaired, assuring the 
individual is fully capable of performing required tasks, maintaining the safety of themselves and 
those around them. At the time of hiring, an individual may be required to take a urine drug test. 
Depending on state laws and employer’s policies, the individual may be subject to additional drug 
testing throughout their employement.21 Most companies choose to test for illegal drugs using 
urine because sample collection is more convenient and less invasive than blood samples, with a 
broader window of detection.22  
In 1981, the Drug Demand Reduction Program (DDRP) was mandated to “deter and 
detect illicit drug use by [Department of Defense] military and civilian personnel.”23 Before the 
mandate of DDRP, stimulant drugs had been provided to combat personnel as a means to lessen 
fatigue and reduce pain.24 In order to counter the drug use, the Department of Defense (DoD) 
implemented educational training and random urine drug tests for those who violated the ‘zero 
tolerance’ mandate.23 In 2011, the DoD analyzed 5.145 million specimens.23 From 2007 to 2011 
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the DoD saw an increase in urine samples testing positive for marijuana, d-amphetamine, d-
methamphetamine, codeine, morphine, heroin, oxycodone, and oxycodone.23 Marijuana was the 
primary illicit drug DoD personnel tested positive for from 2007 to 2011.23 In 2016, Larson et al. 
published an article about their research of drug usage in enlisted Army personnel after their 
deployment. Larson et al. used a urine drug test panel that included: metabolites of cocaine, 
metabolites of heroin, metabolites of delta-9-Tetrahydrocannabinol (THC), d-amphetamine, d-
methamphetamine, Methylenedioxyamphetamine (MDA), Methylenedioxyethylamphetamine 
(MDEA), and Methylenedioxymethamphetamine (MDMA).25 They initially tested the individual 
0 to 6 months after return from deployment and then 6 months to 3 years postdeployment.25 For 
both active duty and national guard/reserve personnel there was an increase in drug usage when 
the 6 month to 3 year urine samples were tested.25 One pitfall as to how the data was reported, 
was that it did not break down the statistics for the particular drugs. Professional athletes are 
subjected to urinary drug testing to assess if performance-enhancing drugs are taken. Each year 
the World Anti-Doping Agency publishes a comprehensive list of prohibited substances.26 
Known drug abusers are routinely drug tested, and the frequency of the drug tests is based on the 
individual’s treatment plan and/or the court’s sentencing. 
2.2.3 Urine drug excretion 
Kidneys perform multiple tasks; however, the one of interest for this research is the 
kidneys’ ability to filter blood to excrete drugs and drug metabolites through the urine.27 For urine 
to be formed from filtered blood, the following 3 processes must occur: filtration, secretion, and 
reabsorption.27,28 Filtration occurs based on the charge and size of molecules. Since opposites 
attract, the negatively charged filtration system draws through positively charged molecules, 
leaving negatively charged molecules behind.27 Smaller molecules are permitted to pass through, 
while bulkier substances remain in the system for the time being.  
Secretion assists in the elimination of the bulkier substances, particularly those that are 
protein bound. Some carrier proteins, which reside within the epithelial wall, can separate drugs 
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bound to plasma. Once the drug has been removed, the carrier protein transfers the drug to the 
kidney tubular fluid.28 Carrier proteins transport either acidic or basic drugs.28 
Reabsorption may also occur. The reabsorption process is necessary for retaining plasma 
and interstitial fluid the human body needs to function.29 However, certain drugs may be 
reabsorbed based on pH and lipid solubility.28 Drugs with pH and solubility similar to that of 
plasma and interstitial fluid will be transported across the membrane, and these drugs will return 
to the bloodstream, eventually returning to the kidney. Between the time the drug cycles back 
through the blood system, it may have had structural changes that result in it not being filtered or 
secreted out of the kidney into the urine.  
2.3 Glucuronides and β-glucuronidase  
 For certain xenobiotics to be excreted from the body, a glucuronide must be attached. 
Glucuronides are a sugar group that are covalently bonded to the xenobiotic through a process 
called glucuronidation, making the xenobiotic more water soluble.30  As the water solubility of 
the xenobiotic is increased, it is more readily excreted from the body in the urine. 
 Prior to analyzing a sample using liquid chromatography-tandem mass spectrometry (LC-
MS/MS), it is common to remove the conjugated glucuronide. Removal of the glucuronide is 
completed using an acidic solution or an enzyme called β-glucuronidase. It is also important to 
consider if the analytical method is looking for analytes with or without glucuronides. The 
approximate molecular weight of the analyte of interest is used for LC-MS/MS, so in the event 
the method file only accounts for the molecular weight of the specific parent analyte, the 
glucuronides must be cleaved off. However, if the analytical method is looking for the 
glucuronide conjugate, then it would not need to be converted back to parent compound.   
2.4 Dilute and Shoot Method 
Dilute and shoot (DS) is the most common technique of urine sample preparation for LC-
MS/MS analysis. DS gained its popularity due to the ease of sample preparation.5As the name 
suggests, a urine sample is diluted before “shooting” the sample on the instrument. Facilities that 
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use the DS technique have their variations of the technique. Cao et al performed DS by 
centrifuging the urine sample, removing an aliquot, adding internal standard and sample diluent 
to the aliquot, and then injecting the sample for analysis.5 Conversely, Kong et al. chose to 
combine an aliquot of sample with internal standard, centrifuge, and pipet off the supernatant to 
be injected for analysis.31 Deventer et al varied the DS technique based on the drug of interest; 
samples with internal standard were either only centrifuged, only filtered, or centrifuged and 
filtered.32 While there is variation among these DS techniques, ultimately each dilutes the sample 
in some fashion and includes the addition of internal standard. 
Urine, naturally excreted through urination, is filled with various substances that might 
interfere with LC-MS/MS analysis. Much of urine is water (91-96%), with the remaining portion 
consisting of organic solvents, inorganic ions, fatty acids, enzymes, carbohydrates, hormones, 
mucins, and pigments.33 The amount of these other items within urine are based on kidney 
function. Therefore, there are some urine samples that have more components, at higher 
concentrations, than others. Though the additional components of urine are necessary for life, 
they are not beneficial to the analysis of urine samples for drugs. Samples are often vortexed to 
create a pellet of the unnecessary components of urine at the bottom of the tube. When 
unnecessary components have been excluded from the overall urine sample, the remaining liquid 
is a cleaner form, ready to be injected onto the instrument for analysis.  
2.5 Volumetric Absorptive Microsampling (VAMS) 
The device used for Volumetric Absorptive Microsampling (VAMS) is a plastic holder 
with a porous absorptive tip, which is manufactured to draw up a specific amount of sample by 
way of capillary action. Tips can be purchased to have an absorptive volume of 10 or 20 µL.34 
VAMS tips are cited to be compatible with 8 fluid types; however, blood and plasma are the most 
widely researched.34 At the time research was conducted, one article was published that evaluated 
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urine and oral fluid.3 At the time thesis writing was being completed, a second article was 
published that assessed urine.35 
2.5.1 Body fluids most researched with VAMS- Blood and Plasma 
VAMS has been being researched as an alternative to dried blood sampling (DBS) since 
2014.36 DBS consists of spotting a blood droplet onto a filter card and allowing the blood to dry, 
and has been previously established as feasible for drug detection..36 When it comes to 
transportation and storage, DBS has advantages to that of wet blood samples. Because the blood 
is dried, there is no need for cooling and hazardous transportation arrangements. Additionally, the 
cards can more easily be stored and packaged than specimen vials. Despite these advantages to 
DBS, there are still flaws. The greatest concern is obtaining a consistent amount of sample, as 
there are no specific requirements for the volume of blood that must be spotted on the card or 
specific technique used for spotting.36 Hematocrit (HCT), the number of red blood cells, affects 
the consistency of blood, which will factor into how much sample volume is being spotted.36,37 
When there is a lower concentration of HCT, the blood is less viscous, which in turn means the 
sample is spread more easily, making for a larger blood spot. 
Comparative research has been conducted to assess if VAMS is a viable alternative to 
DBS. Denniff and Spooner appear to be the first to publish their research comparing DBS and 
VAMS in terms of HCT concentration in 2014.36 Using the 10 µL VAMS tips, Denniff and 
Spooner found that the average volume of sample drawn up, regardless of HCT concentration 
was 10.5 ± 0.1 µL.36 Additionally, a test was conducted to evaluate the variability of VAMS 
between users. It was found that, “…VAMS has similar volume errors to other already accepted 
and established techniques.” 36 Another element of VAMS that Denniff and Spooner evaluated 
was the amount of additional volume that would be collected in the event of the microsampling 
tip being fully submerged in the blood sample. When fully submerged, the volume increased by 
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26% or greater than the control average of 10.5 µL.36 This finding emphasizes the importance of 
proper training using VAMS. 
The following year, De Kesel et al performed similar experimentation to evaluate how 
the HCT concentration would factor in to blood sample collection using VAMS. De Kesel et al 
was more interested in the concentration of caffeine and paraxanthine, a caffeine metabolite, than 
the volume of sample collected.38 At the time of their research, the VAMS manufacturer reported 
the 10 µL tip absorbed an average of 10.7 µL. While Denniff and Spooner had only compared 
DBS and VAMS, De Kesel et al expanded out to compare DBS and VAMS to wet whole blood 
samples.38 It was reported there was less variation in drug concentrations when using VAMS 
regardless of the concentration of HCT when analyzed using LC-MS/MS.38 Additionally, it was 
observed that “recovery was somewhat lower for the IS than for the analyte...” when using 
VAMS.38 
In 2016, Bolea-Fernandez et al evaluated VAMS using whole blood as an alternative to 
venipuncture and DBS testing for metals in individuals that received metallic prosthetics.39 When 
it came to ultra-trace amount testing, Al, Cr, and Ni, were the metals in the study that were found 
to not be suitable for VAMS blood testing.39 The authors speculated that those particular metals 
may have been used in the production process of making the VAMS tips, which resulted in the 
increased concentrations of those metals.39 However, the remaining metals were successfully 
qualified and quantified through inductively coupled plasma – mass spectrometry (ICP-MS).39 
Barco et al compared the concentration of four antibiotics in DBS, dried VAMS, and wet 
plasma through LC-MS/MS testing.40 It was found that the concertation of the antibiotics across 
the three methods were highly comparable, with a relative standard deviation of 12%.40 In 
addition, an evaluation of analyte stability for VAMS was performed. Over short term storage of 
72 hours, all antibiotics had minimal loss when stored at -20°C or 4°C. 40 When stored at room 
temperature for short term, one antibiotic experienced 20-35% loss. 40 Over long term storage of 1 
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month, all antibiotics had minimal loss when stored at -20°C. Conversely, all antibiotics 
experienced 22-36% loss when stored at 4°C or room temperature for long term.40 
While more research must still be conducted, several studies have so far found VAMS 
possess the potential to be an alternative, if not replacement, of DBS.36,38,39,40,41, 
2.5.2 VAMS in Urine 
At the time of this research project, there had been one publication about the use of 
VAMS for drug identification in dried urine samples. Mercolini et al. compared dried urine, 
plasma, and oral fluid to the wet matrix for the quantification of cathinone analogues.3 Cathinones 
are a psychoactive stimulant similar to amphetamines. 3 They are more commonly referred to as 
“bath salts.” 3 Through their research, Mercolini et al. found cathinones to degrade in wet 
samples. 3 In order to properly identify and quantify cathinone analogues a dried urine sample is 
ideal. Ultimately, Mercolini et al. found that “the sampling/processing methods demonstrated a 
good equivalence between conventional wet samples and dried samples collect on VAMS 
devices.”3  
During the writing process of this thesis, a second journal article was published regarding 
dried urine with VAMS. Protti et al. compared wet plasma to dried blood spots (DBS) and dried 
plasma spots (DPS), and wet urine to dried VAMS and dried urine spots (DUS).35  Protti et al.’s 
research focused on oxycodone, oxymorphone, and noroxycodone. 35  Similarly to Mercolini et 
al., Protti et al. found that certain analytes of interest were more stable in dried matrices rather 
than wet.35 However, when it came to comparing the dried samples to each other with their 
respective matrix, Protti et al. found there to be “no clear winner...”35 
At this time there is limited information when it comes to VAMS being used with dried 
urine samples for drug testing. Therefore, additional studies are necessary to establish the validity 




2.6 Liquid Chromatography – Tandem Mass Spectrometry 
Liquid chromatography – tandem mass spectrometry (LC-MS/MS) combines the polar 
separation capabilities of LC with that of tandem MS to ionize and sort molecules based on mass-
to-charge (m/z) ratios.42 
2.6.1 Liquid Chromatography 
Liquid chromatography may be used in either planar or column techniques. Column LC 
is what was used in this research. The column provides a stationary phase, for the molecules to 
flow through, with the application of mobile phases of varying hydrophilicity. In the case of a 
non-polar stationary phase, polar molecules will elute off the column with an aqueous (polar) 
mobile phase at a faster rate. The more polar the molecule, the faster it will come off the column. 
A gradual transition from aqueous to organic (non-polar) mobile phase occurs, creating an 
increased non-polar environment. Non-polar molecules that remained in the column will now 
elute off in the non-polar mobile phase. With high pressure liquid chromatography (HPLC), a 
high pressure system is used to assist in moving the mobile phases, and thus the analytes of 
interest, through the column.43 
The time at which molecules elute off the column is termed the retention time. The 
retention time is specific to the molecule, mobile phases used, and the concentration gradient of 
the mobile phases. However, it is possible for molecules to coelute, meaning they come off the 
column at the same retention time. In instances of coelution, it is important to have a secondary 
analysis is completed to ascertain what the molecule is, such as a mass spectrometer.42 
2.6.2 Mass Spectrometry 
Mass spectrometry measures ionized analytes.44 In the case of a triple quadrupole 
MS/MS, as seen in Figure 1, sorting and measurement of ions take place in three stages. 
Quadrupole typically refers to the fact that there are four rods or poles arranged around the ion 
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flow to act as mass filters. Radio frequencies and direct current voltages applied to the poles 
allow only ions with a specified m/z ratio through to the detector. 44 Figure 1 shows the 
configuration of a tandem mass spectrometer, or triple quadrupole instrument, in which the first 
and third quadrupoles act as mass filters and the second quadrupole serves as a collision cell. 
 
Figure 1. Triple quadrupole of tandem mass spectrometer. (Taken from Ni J, Ouyang H, Aiello 
M, et al. Microdosing Assessment to Evaluate Pharmacokinetics and Drug Metabolism in 
Rats Using Liquid Chromatography-Tandem Mass Spectrometry. Pharm Res. 
2008;25(7):1572-1582. doi:10.1007/s11095-008-9555-x) 
 
Specifically, in the first quadrupole (Q1) the spectrometer is set to filter only ions of a 
specific m/z ratio. For example, oxycodone is known to have a m/z ratio of 315.90. Ions with the 
specified m/z ratio are allowed through to Q2, where a specific amount of energy is applied, 
resulting in ion collision and fragmentation of the target analyte. Continuing with the example of 
oxycodone, when collision energy is applied to oxycodone it is known to fragment into 298.15 
and 241.10 m/z. Q3 of the spectrometer will then allow only these specific m/z ratios to pass to 
the detector. The combination of the Q1 and Q3 m/z targets are called a transition, and the 






While doctors can be careful about for who and how they write prescriptions, there is still 
the need to ensure prescription compliance for the safety of the patient being treated. Urine is 
ideal for drug testing because the collection is noninvasive and easy, and it has a wider detection 
window for drugs than blood. Additionally, urine drug testing using LC-MS/MS allows for a 
variety of drugs to be detected.  
Dilute and shoot (DS) has traditionally been the technique of choice for urine sample 
extraction. The popularity of DS is due in part to the fact that until VAMS, there had not been a 
viable technique available for testing dry, rather than traditional wet, urine samples. The goal of 
this research is to compare the wet dilute and shoot technique to dry VAMS technique for urine 
drug testing for analysis on LC-MS/MS. From this research, it may be determined whether or not 
dry urine testing with VAMS is as reliable for drug identification in urine samples as that of the 









The purpose of this research project was to determine the effectiveness and efficiency of two 
urine drug identification techniques, wet urine using dilute and shoot and dry urine using VAMS 
tips. The research was conducted as a two-part study. The first part of the study involved the 
development of a hydrolysis method for the VAMS tips and to determine the percent recovery of 
hydrolyzed glucuronides. This was accomplished by calculating the hydrolyzing efficiency of 
glucuronidase enzymes using known amounts of glucuronide conjugates across multiple drug 
classes.  The second part of the study pertained to anonymized samples that had been analyzed 
clinically using a validated DS technique. These samples were used to compare each technique’s 
ability to identify the drugs present in the specimens at various concentrations. All samples were 
analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) at Oklahoma 
State University – Clinical Laboratory Services (OSU-CLS).  
3.2 Materials 
All drugs in Tables 1 - 3 were purchased from Cerilliant (Cerilliant Corporation, Round 
Rock, TX) in the specified concentrations. Methanol was purchased from JT Baker (Avantor  
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Performance Materials Inc., Center Valley, PA). Formic acid and glacial acetic acid were 
purchased from EDM (EDM Millipore Corporation, Billerica, MA). Isopropanol was purchased 
from Honeywell (VWR International, Randor, PA). HPLC grade water was obtained from a 
Barnstead Nanopure water system (Thermo Scientific, Waltham, MA). Ammonium formate was 
purchased from Alfa Aesar (Alfa Aesar, Ward Hill, MA). Sodium acetate was purchased from 
BDH (VWR International, Randor, PA). Drug-free urine was purchased from UTAK (UTAK 
Laboratories Inc., Valencia, CA). β-glucuronidase was purchased from Campbell Science 
(Campbell Science, Rockford, IL). IMCSzyme and rapid hydrolysis buffer were purchased from 
IMCS (IMCS, Irmo, SC). Mitra ® microsampling devices were obtained from Neoteryx for a 
collection volume of 20 µL (Neoteryx, Torrance, CA). 











Hydromorphone (-)-11-nor-9-Carboxy-delta9-THC (THCA) 
Lorazepam Tramadol 




Table 2. Glucuronide conjugates purchased from Cerilliant at 100.0 µg/mL. 
 
Codeine-6β-D-glucuronide Oxazepam glucuronide 





















3.3 Solution Preparation 
3.3.1 Standards 
3.3.1.1 Internal standard. A total of 5.0 mL of the internal standard was prepared in 
methanol as described in Table 4. The total volume of internal standards came to 1040 µL, and 
the remaining 3960 µL consisted of methanol. Internal standard was prepared in advance and 
stored at 4°C until ready for use, expiring 1 year from the date it was made. 
Table 4. Preparation of 5.0 mL of internal standard solution. Total internal standard 









Amphetamine-D5 10.0 2.0 
Benzoylecgonine-D3 50.0 1.0 
Codeine-D6 10.0 2.0 
Diazepam-D5 250.0 5.0 
Fentanyl-D5 50.0 1.0 
Gabapentin-D10 50.0 1.0 
Hydromorphone-D3 10.0 2.0 
Morphine-D6 500.0 10.0 
Normeperidine-D4 50.0 1.0 
Oxycodone-D6 10.0 2.0 
(+)-11-nor-9-Carboxy-delta9-THC-D3 50.0 10.0 
 
 
3.3.1.2 Calibration curve. A calibration curve was prepared to run alongside the 
glucuronide mix and unknown samples to quantify the drug concentrations. A calibration curve 
provides a range of quantitation. A 1 mL calibration stock solution was prepared for analytes to 
be at a final concentration of 1000 ng/mL in UTAK urine, the necessary spike volumes are stated 
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in Table 5. Of the prepared 1.0 mL of 1000 ng/mL stock, 500 µL was used to generate a stock of 
500 ng/mL with 500 µL of UTAK urine. This 500 ng/mL solution was used as the starting 
concentration for preparing the curve. A total of 6 calibration points were made that ranged from 
a lower limit of quantitation of 20 ng/mL to an upper limit of quantitation of 500 ng/mL. The 
concentrations for each of the 6 calibration points are listed in Table 6. Calibration levels were 
prepared by using the previous calibration level and UTAK urine, with the specific volumes 
necessary for curve production as presented in Table 7. The prepared calibration curve was 
compared to a validated OSU-CLS calibration curve. 
Table 5. Preparation of calibration stock solution for a final concentration of 1000 
ng/mL. Total spike volume was 40 µL. UTAK urine volume was 960 µL. 
 































Table 6. Concentrations of each drug mentioned in Table 5 at the specific level. 
 
Concentration (ng/mL) Level 
500.0 25.0 c 
300.0 15.0 c 
200.0 10.0 c 
150.0 7.5 c 
50.0 2.5 c 
20.0 1.0 c 
 
Table 7. Preparation of the 6 calibration points starting from a concentration of 500 

























25.0c 175           1575 1750 718 
15.0c   1032         688 1720 700 
10.0c     1020       510 1530 720 
7.5c       810     270 1080 700 
2.5c          380   760 1140 720 
1.0c           420 630 1050 700 
 
 
3.3.1.3 OSU-CLS quality control. Validated quality control (QC) standards were obtained 
from OSU-CLS. This was done as an additional measure to ensure the quality of calibration 
curve. 
3.3.2 Glucuronide conjugate mix. The glucuronide conjugate mix used was prepared 
from a stock solution where each of the five glucuronide conjugates was at a final concentration 
of 500 ng/mL in methanol. An aliquot of the stock solution was diluted in half for a final 
concentration of 250 ng/mL in methanol. 
3.3.3 Unknown samples. Unknown samples were anonymized samples. A total of ten 







3.4.1 Dilute and Shoot 
3.4.1.1 Overview. Dilute and shoot (DS) is a technique in which a sample is diluted 
before being injected (shot) onto an instrument. The DS procedure used in this study was the 
clinically validated procedure used at the OSU-CLS. 
3.4.1.2 Methodology. Because the DS procedure used was a validated method of OSU-
CLS, there was no need for method development. A fresh batch of hydrolysis solution was 
prepared for each sample batch. Hydrolysis is the act of cleaving off a sugar group to produce the 
parent drug. This hydrolysis solution consisted of 20 µL internal standard, 25 µL sodium acetate 
buffer pH 4.0, and 10 µL Campbell’s β-glucuronidase per sample. Once the reagents are added 
together, it was vortexed for 10 seconds using a VWR signature mini vortexer (VWR 
International, Randor, PA), followed by centrifugation at 13 000 RPM for 10 minutes with a 
Heraeus Pico 17 centrifuge (Thermo Scientific, Waltham, MA). 
 Into each 1.5 mL Eppendorf tube, 50 µL of hydrolysis was added; then 50 µL of sample 
was added to its respective tube. Each tube was vortexed for 10 seconds. Samples were incubated 
at 55°C for two hours in a VWR mini incubator (VWR International, Randor, PA). When 
incubation was complete, 150 µL of 1:9 methanol to water sample diluent was added.  
 Each sample was vortexed for 10 seconds. Samples were then centrifuged at 30 000 RPM 
for 10 minutes in an Eppendorf Centrifuge 5424 (VWR International, Randor, PA). Upon 
completion of centrifugation, 200 µL of supernatant was placed into the respective injection vial. 
A lid to the injection vial was secured in place. Samples were then ready to be placed on the 







3.4.2 Microsampling Tips 
3.4.2.1 Overview. The Neoteryx Mitra ® VAMS devices used in this research were 
designed to collect 20 µL of sample. Figure 2 is an image of the microtip. These VAMS devices 




Figure 2. Neoteryx Mitra ® microsampling device, 20 µL. 
 
 
3.4.2.2 Volume evaluation. The Neoteryx Mitra ® microsampling devices used in this 
research were manufactured to absorb 20 µL of a solution. A test was conducted to determine the 
amount of liquid that was truly absorbed by the tip in the time it took the solution to be absorbed 
plus an addition 6 seconds. This test was conducted using two mediums: deionized water and 
blank urine. The temperature of the work space was recorded at the start and end of the 
experiment. A 5-mL disposable polystyrene beaker (Fisher Scientific, Hampton, NH) was placed 
on the XS64 analytical balance (Mettler Toledo, Columbus, OH) and then tared. A 1000 µL pipet 
was used to mass 1 mL of deionized water 3 times. Between each addition the mass was recorded 
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in grams and tared before the next 1 mL was added. This same process was repeated using blank 
urine, collecting a total of 3 masses.  
 A 5-mL disposable polystyrene beaker with approximately 3 mL of deionized water was 
placed on the analytical balance and tared. A Neoteryx Mitra ® microsampling device was 
dipped into the solution enough to make contact with the water but not enough to fully submerge 
the tip. A very subtle color change was observed as the water was absorbed. The microtip was 
held in the water an additional 6 seconds after the tip experienced a complete change in color. 
The absolute values of the change in mass in grams were recorded and the analytical balance was 
tared. This was repeated 2 more times, using different microsampling tips. Another set of 3 
microsampling tips were used when repeating the process with blank urine. 
 The volume absorbed by each tip was calculated using the mass absorbed and the average 
solution density of the respective solution. The three volumes were averaged to determine the 
average volume of deionized water and blank urine absorbed by the Neoteryx Mitra ® 
microsampling tips.  
3.4.2.3 Method development. When developing a method for the Volumetric Absorptive 
Microsampling (VAMS) tips extraction technique, the hope was to use similar, if not the same, 
ratios of each reagent as that of the DS technique. VAMS samples were to be collected per the 
recommendation of the manufacturer.  
To remove drugs from the tip, the tips were sonicated in solution containing an internal 
standard. Initially, the intent was to use 10 µL of internal standard and 30 µL of sodium acetate 
buffer pH 4.0, the same buffer used in the DS technique. However, 40 µL was not enough 
solution to fully submerge the tip in the Eppendorf tube. Therefore, the volume of acetate buffer 
was increased to 80 µL, making for a final volume of 90 µL. Samples were then sonicated for 15 
minutes. After sonication, the solution was injected onto the LC-MS/MS. At this time, no β-
glucuronidase enzyme was used because the recovery of drugs bound to glucuronides was not the 
objective. Instead, the objective was to determine if drugs and internal standard were able to be 
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seen using 80 µL of acetate buffer and 10 µL of internal standard. Upon analysis with LC-
MS/MS it was determined that sodium acetate buffer pH 4.0 was not able to remove drugs from 
the VAMS tip. Additionally, identification of internal standards was minimal. From a literature 
review, it was determined that methanol and acetonitrile had been successfully used in other 
studies using VAMS during sonication in order to extract drugs from the VAMS tip. The 
experiment was repeated, one using methanol, the other using acetonitrile, and LC-MS/MS 
analysis was conducted. The results for the sample using methanol and the sample using 
acetonitrile were very comparable, as in both instances, drugs and internal standards were easily 
identifiable. It was decided to proceed with methanol since that is the basis of the 
chromatography mobile phase used in this research.  
The next step was to determine the lower limit of quantitation for drugs. Many of the drugs in 
the OSU-CLS validated DS method were known to be identifiable down to 15 or 20 ng/mL, 
except for (-)-11-nor-9-Carboxy-delta9-THC (THCA) at 150 ng/mL. UTAK urine was fortified to 
20 ng/mL for all the analytes, then samples were collected and allowed to dry for 3 hours. They 
were then submerged into 90 µL of 1:8 mix of internal standard to methanol and sonicated for 15 
minutes. At this time, no β-glucuronidase enzyme was used, because the spiked urine did not 
contain glucuronide conjugates. Analysis with LC-MS/MS determined that aside from THCA, 
drugs were able to be seen down to 20 ng/mL. It was determined that the lower limit of the 
calibration curve would be 20 ng/mL for all drugs, realizing that THCA would not be able to be 
seen at that level. 
The activity of β-glucuronidase is known to be disrupted by methanol. As methanol is being 
used to dislodge the drugs from the VAMS tip, it must be removed prior to the addition of the 
enzyme. A test was conducted by putting 20 µL of each of the calibration curve points or 20 µL 
of a 200 ng/mL glucuronide mix into individual Eppendorf tubes, then adding 90 µL of the 1:8 
mix of internal standard to methanol to each tube. At this point in time, VAMS tips were not used 
because the goal was proof of concept. Samples were dried down on a SPEware CEREX 48 
26 
 
sample concentrator (Tecan SP, Inc., Baldwin Park, CA). Originally the thought was to just dry 
off the methanol. However, it proved challenging to determine exactly when the methanol was 
fully gone from the sample. Therefore, in order to achieve complete dryness, the drying took 
place for 1 hour with the nitrogen dry down gas at 60°C. Once drying was complete, 25 µL of 
IMCS mix, consisting of 10 µL enzyme and 15 µL of buffer, were added to the Eppendorf tubes. 
Samples were then incubated for 30 minutes at 55°C, 40 µL of a 1:9 methanol to water sample 
diluent was added, and the resultant samples were analyzed using LC-MS/MS. From analysis, the 
calibration curve and glucuronide mix appeared to provide results consistent with functional 
enzyme. 
The idea of increasing glucuronide recovery by altering the amount of enzyme used was 
evaluated. The following was added to an Eppendorf tube: 90 µL of the 1:8 mix of internal 
standard to methanol and either 20 µL of the calibration curve points or 20 µL of a 200 ng/mL 
glucuronide mix. Three separate glucuronide mix tubes were prepared. Sonication occurred for 15 
mins, followed by dry down on the SPEware CEREX for 1 hour at 60°C. The first glucuronide 
tube received 10 µL IMCS enzyme and 15 µL of IMCS buffer. The second glucuronide tube 
received 20 µL IMCS enzyme and 30 µL of IMCS buffer. The third glucuronide tube received 30 
µL IMCS enzyme and 45 µL of IMCS buffer. All curve samples received 35 µL of HPLC grade 
water because there were no glucuronides to cleave. Samples were vortexed for 10 seconds and 
incubated for 30 minutes at 55°C. When incubation was complete, sample diluent was added to 
all tubes. The first glucuronide tube received 75 µL of sample diluent, second glucuronide tube 
received 50 µL of sample diluent, and the third glucuronide tube received 25 µL of sample 
diluent. The curve samples received 65 µL of sample diluent, bringing the total volume for all 
tubes to 100 µL. All samples were vortexed for 10 seconds and centrifuged for 10 minutes at 
13,000 RPM. After LC-MS/MS analysis, minimal difference was observed in between the 3 
glucuronide samples. The overall volume of the sample supernatant was raised from 65 µL to 100 
µL to allow for additional injections on the instrument, should it be necessary. 
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Using methanol as the solvent for sonication worked; however, 1 hour was being spent drying 
down the sample. In an effort to speed up the dry down process, dichloromethane (DCM) was 
used in place of methanol. Internal standard and DCM were found to be immiscible with each 
other. Once more, 20 µL of each calibration curve points were added to their respective 
Eppendorf tubes. After 15 minutes of sonication no solvent was present in the Eppendorf tubes, 
therefore no dry down was necessary. In place of enzyme and buffer, 25µL of HPLC water was 
used and 75 µL of sample diluent was added. The sample was then injected onto the LC-MS/MS. 
Using DCM, not all of the drug analytes and internal standards were able to be recovered. 
Therefore, it was accepted that methanol and drying down was the most viable option for drug 
extraction from the VAMS tips for analysis using LC-MS/MS.  
3.4.2.4 Urine VAMS Methodology.  Labeled microtips were dipped into the sample, 
enough to break the surface of the urine, but not enough to fully submerge the tip. A slight color 
change was observed on the microtip as the urine was absorbed. The microtip was held in the 
urine an additional 6 seconds after the tip experienced a complete change in color. Samples were 
permitted to dry at room temperature for 3 hours. 
A stock of internal standard/methanol mix was prepared at the start of each batch. Stocks 
were prepared at a ratio of 1:8 mix of internal standard to methanol. Once dried, samples were 
placed in the respective 1.5 mL Eppendorf tube that contained 90 µL of the internal 
standard/methanol mix. Figure 3 shows what the microtip looked like once in the Eppendorf tube. 




Figure 3. VAMS tip submerged in internal standard/methanol mix. 
 
 
Samples were sonicated for 15 minutes using a B2500A-MTH ultrasonics cleaner (VWR 
International, Randor, PA). The lids of the Eppendorf tubes remained open because the 
microsampling tip extended past the top of the tube. Upon completion of sonication, the 
microsampling devices were removed from the tubes. 
Samples were transferred to a drying rack and dried on a SPEware CEREX 48 sample 
concentrator (Tecan SP, Inc., Baldwin Park, CA). Samples were dried at with nitrogen gas at 
45°C for 70 minutes, followed by 60°C until completely dry. The time at 60°C ranged from 11 
minutes up to 35 minutes. The rate of drying was a function of the laboratory conditions; on 
humid days samples took longer to dry down. 
A stock of IMCSzyme and rapid hydrolysis buffer was prepared 5 – 10 minutes before 
the dry down completion and stored at 4°C until ready for use. This stock was made so that each 
sample would receive 10 µL of enzyme and 15 µL of buffer. A total of 25 µL of IMCS mix was 
added to the now dried down samples in the Eppendorf tubes. All samples were vortexed for 10 
seconds using a VWR signature mini vortexer (VWR International, Randor, PA), followed by 
incubation at 55°C for 30 minutes in a VWR mini incubator (VWR International, Randor, PA). 
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When incubation was complete, 75 µL of a 1:9 methanol to water sample diluent was 
added, and each sample was vortexed for 10 seconds. Samples were then centrifuged at 30,000 
RPM for 10 minutes in an Eppendorf Centrifuge 5424 (VWR International, Randor, PA). Upon 
completion of centrifugation, 100 µL of supernatant was placed into an insert in the respective 
injection vial, and the lid to the injection vial was secured in place. Samples were then ready to be 
placed on the instrument for analysis. Samples were injected 4 times to allow the researchers to 
perform statistical analysis. 
3.5 Liquid Chromatography-Tandem Mass Spectrometry 
Samples were analyzed using a Shimadzu HPLC system (Shimadzu Corporation, Kyoto, 
Japan) with a CBM-20A control module, 2 LC-AD solvent pump, SIL-20A HT autosampler, 
CTO-20A column oven, and FCV-20AH2 diverter valve. Liquid chromatography separation was 
completed using a Restek® RaptorTM Biphenyl guard column (2.7 µm, 5 x 3.0 mm) and column 
(2.7 µm, 50 x 2.1 mm) (Restek, Bellefonte, PA). The HPLC was attached to the front of a 
Shimadzu LCMS-8040 liquid chromatography tandem mass spectrometer (LC-MS/MS) system.  
The aqueous mobile phase (MPA) consisted of 2 mM ammonium formate and 0.1% 
formic acid in HPLC grade water. The organic mobile phase (MPB) consisted of 2 mM 
ammonium formate and 0.1% formic acid in LCMS methanol. The LC pumps had a total flow 
rate of 0.35 mL/min. Total injection volume was set at 5 µL. MPB concentration began at 10%, 
ramped up to 35% by 1.90 minutes, ramped up to 100% by 3.90 minutes, held at 100% until 4.50 
minutes, then dropped to 10% by 4.51 minutes, where it remained until the end of the 5-minute 
run time (Figure 4). The oven temperature was set at 30°C. Tables 8 and 9 are a comprehensive 
list of the internal standards and drugs in the panel, to include the ion transitions and instrument 
parameters for compound detection. Regardless of the technique used, all samples were analyzed 















Table 8. Analyte internal standards in the panel. Includes LC-MS/MS parameters for ion 













Amphetamine-D5 140.80 93.00 15.00 19.00 35.00 
Benzoylegonine-D5 292.80 171.05 38.00 19.00 30.00 
Codeine-D6 305.90 165.10 40.00 45.00 30.00 
Diazepam-D5 289.90 153.95 50.00 29.00 28.00 
Fentanyl-D5 341.85 105.10 46.00 42.00 38.00 
Gabapentin-D10 182.10 55.05 12.00 27.00 20.00 
Hydromorphone-D3 288.90 184.95 50.00 31.00 34.00 
Morphine-D3 289.10 165.05 15.00 42.00 30.00 
Normeperidine-D4 238.00 42.05 12.00 35.00 44.00 
Oxycodone-D6 321.90 304.15 38.00 20.00 32.00 
(+)-11-nor-9-Carboxy-delta9-THC-D3 348.20 330.20 20.00 15.00 35.00 
a Drugs were identified using two mass ion fragments, internal standards were identified using one mass 
ion fragment. 
b The molecular mass of each analyte measured in Daltons. 
c Unique ion mass fragment measured in Daltons. 
d “DP”, “CE”, and “CXP” refer to voltages used for declustering potential, collision energy, and collision 






Table 9. Analyte drugs in the panel. Includes LC-MS/MS parameters for ion transitions 













6-Acetylmorphine 328.20 165.05 10.00 40.00 30.00  
328.20 58.10 10.00 29.00 20.00 
Alpha-Hydroxyalprazolam 324.90 297.05 16.00 27.00 32.00 
324.90 216.00 16.00 42.00 40.00 
Amphetamine 136.00 91.10 20.00 17.00 15.00  
136.00 119.15 20.00 14.00 45.00 
Benzoylecgonine 289.95 168.05 14.00 19.00 30.00  
289.95 104.95 20.00 29.00 18.00 
Clonazepam 316.20 270.00 50.00 35.00 30.00  
316.20 214.00 50.00 35.00 45.00 
Codeine 299.90 165.00 35.00 43.00 30.00  
299.90 215.00 35.00 28.00 20.00 
Diazepam 284.90 153.95 36.00 28.00 28.00  
284.90 193.00 46.00 34.00 34.00 
Gabapentin 172.20 154.00 30.00 15.00 15.00  
172.20 137.10 30.00 18.00 25.00 
Hydrocodone 299.90 199.00 35.00 40.00 35.00  
300.30 171.10 50.00 40.00 30.00 
Hydromorphone 285.90 185.00 32.00 32.00 34.00  
285.90 157.00 32.00 42.00 26.00 
Lorazepam 320.80 274.90 40.00 23.00 50.00  
320.80 229.00 40.00 30.00 45.00 
Morphine 286.10 165.00 45.00 42.00 30.00  
286.10 155.10 45.00 35.00 15.00 
Norbuprenorphine 414.30 83.10 25.00 54.00 15.00  
414.30 101.20 24.00 40.00 40.00 
Nordiazepam 271.20 139.90 18.00 29.00 24.00  
271.20 208.10 18.00 30.00 40.00 
Norhydrocodone 285.90 198.95 32.00 30.00 36.00  
286.00 127.95 14.00 55.00 46.00 
Noroxycodone 302.10 187.00 50.00 26.00 35.00  
302.10 227.10 50.00 28.00 15.00 
Oxazepam 287.20 241.00 50.00 23.00 25.00  
287.20 104.00 15.00 34.00 40.00 
Oxycodone 315.90 298.15 40.00 30.00 30.00  
316.30 241.10 50.00 30.00 45.00 
Oxymorphone 301.90 227.00 34.00 30.00 40.00  
301.90 198.00 34.00 48.00 36.00 
Temazepam 301.10 255.00 20.00 40.00 25.00  
301.20 176.90 20.00 40.00 30.00 
(-)-11-nor-9-Carboxy-
delta9-THC (THCA) 
345.20 299.15 50.00 20.00 20.00 
345.00 193.10 45.00 26.00 35.00 
Tramadol 263.60 264.10 30.00 7.00 30.00 
 264.20 58.05 10.00 10.00 20.00 
a Drugs were identified using two mass ion fragments, internal standards were identified using one 
mass ion fragment. 
b The molecular mass of each analyte measured in Daltons. 
c Unique ion mass fragment measured in Daltons. 
d “DP”, “CE”, and “CXP” refer to voltages used for declustering potential, collision energy, and 





3.6 Data Analysis 
Statistical analysis for quantification of analytes within samples was completed using 
Microsoft Excel (Microsoft Office, Microsoft Corporation, Redmond, WA) and GraphPad Prism 
7.03 (GraphPad Software, La Jolla, CA). It was known that the concentration of the glucuronide 
conjugates was to be 250 ng/mL. Percent efficiency of drug recovery was calculated for each 
injection, as well as the average of the triplicate injections. Two-tailed t-tests were completed to 
determine if there was a statistically significant difference between the concentration of each drug 
in the samples based on the technique used. 
3.7 Conclusion  
Blank urine was fortified with a glucuronide conjugate mix at 250 ng/mL and unknown 
samples with drugs in the method panel were evaluated. The wet and dry techniques were 
performed on each of these samples. LC-MS/MS was used for identification and quantification of 
each analyte. Data analysis was performed to determine if there was a statistical difference 








4.1 Glucuronide Conjugate Mix 
The percent efficiency of the glucuronide conjugates recovered in each sample, from 
each injection, was determined by dividing the concentration reported from LC-MS/MS in ng/mL 
by the theoretical maximum of 250 ng/mL, then multiplying by 100. Mean percent efficiencies 
were then determined for DS and VAMS tips. The two-tailed t-test comparing the mean percent 
efficiencies of DS and VAMS tips for each of the 5 glucuronides are summarized in Table 10. 
Table 10. Two-tailed t-test analysis of glucuronide efficiency. 
 
Mean % Efficiency 
Drug DS Tip 
Codeine*** 28.7 57.0 
Lorazepam** 50.6 62.5 
Morphine* 50.8 58.9 
Oxazepam** 49.3 58.6 
THCA* 66.1 88.0 
* p-value ≤ 0.05 ** p-value ≤ 0.01 *** p-value ≤ 0.001 
N = 4 
 
4.2 Volume Evaluation 
The microsampling tips obtained from Neoteryx was reported to absorb 20 µL of sample. 
The mean density of deionized water was determined to be 1.002 g/mL. The mean density of 
UTAK urine was determined to be 0.982 g/mL. Based on the mass of deionized water or UTAK 
urine absorbed by the microsampling tips, the mean volume of solution absorbed by the tip was 
25.6 and 27.2 µL, respectively. A two-tailed t-test was conducted, determining there was not a 
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significant difference between the volume of deionized water and UTAK urine absorbed. A two-
tailed t-test was conducted to evaluate the difference between the volume of deionized water and 
UTAK urine absorbed compared to the 20 µL the Neoteryx Mitra ® microsampling device was 
intended to absorb. 
Based on the findings of the microsampling tip volume experiment, the experiment was 
repeated at a later date to determine the true volume taken up when pipetting 50 µL. The mean 
density of deionized water was determined to be 1.004 g/mL. The mean density of UTAK urine 
was determined to be 0.977 g/mL. Based on the mass of deionized water or UTAK urine drawn 
up by the pipet, the mean volume of solution was 49.8 and 51.2 µL, respectively. A two-tailed t-
test was conducted using a p-value < 0.05, which determined there is not a significant difference 
between the volumes drawn up during the pipet volume test. 
4.3 Internal Standard Comparison 
A comparison of the areas of internal standards (IS) under the curve, QC’s, and blanks 
were made. All ISs had significantly different areas given the two extraction techniques, as shown 
in Table 11. The ratio difference of sample to resuspension volume was minimal between the two 
techniques. DS used 50 µL of sample and had a resuspension volume of 200 µL, while VAMS 








Table 11. Two-tailed t-test analysis of average IS area in DS and microsampling tip 
extraction techniques. 
 DS Tip 
Amphetamine-D5 11,900,336 7,290,158 
Benzoylecgonine-D3 4,439,902 2,654,737 
Codeine-D6 458,506 275,922 
Diazepam-D5 1,698,232 897,732 
Fentanyl-D5 4,023,548 2,156,112 
Gabapentin-D10 958,379 554,722 
Hydromorphone-D3 939,752 511,121 
Morphine-D6 3,011,061 1,636,919 
Normeperidine-D4 1,061,516 631,915 
Oxycodone-D6 10,686,960 5,728,450 
THCA-D3 59,580 1,152,184 
All significantly different when two-tailed t-test conducted 
with p-value < 0.05 is used. 
N = 23 
 
4.4 Unknown Samples 
The 10 unknown samples were evaluated for the 22 drugs using the two techniques. 
Drugs with a concentration greater than the lower limit of quantitation are considered positive for 
the particular drug. Drugs with a concentration less than the lower limit of quantitation are 
considered negative. The qualitative results of drugs present in the unknown samples by DS or 








Table 12. Unknown samples positive or negative for drugs based on being greater or less 
than the lower limit of quantitation, separated by extraction technique. 
 
1 2 3 4 5 6 7 8 9 10 
  DS Tip DS Tip DS Tip DS Tip DS Tip DS Tip DS Tip DS Tip DS Tip DS Tip 
6-MAM - - - - - - - - - - - - - - - - - - - - 
α-
Hydroxyalprazolam 
- - - - - - - - - - - - - - - - - - - - 
Amphetamine - - - - + + - - - - - - - - - - + + - - 
Benzoylecgonine - - - - - - - - - - - - - - - - - - - - 
Clonazepam - - - - - - - - - - - - - - - - - - - - 
Codeine + + - - - - - - - - - - - - - - - - + + 
Diazepam - - - - - - - - - - - - - - - - - - - - 
Gabapentin + + + + + + - - - - + + - - - - - - +† + 
Hydrocodone -* + - - - - - - + + - - - - + + + + - - 
Hydromorphone - - - - - - - - - - - - - - + + + + + + 
Lorazepam - - - - - - - - - - - - - - - - - - - - 
Morphine + + - - - - - - - - - - - - - - - - + + 
Norbuprenorphine - - + + - - - - - - - - - - - - - - - - 
Nordiazepam - - - - -* + + + - - - - - - - - - - - - 
Norhydrocodone + + - - - - - - - - - - - - + + + + - - 
Noroxycodone + + - - + + + + + + + + + + - - - - - - 
Oxazepam - - - - + + + + - - + + - - - - - - - - 
Oxycodone - - - - + + + + + + + + + + - - - - - - 
Oxymorphone - - - - + + + + + + + + + + - - + + - - 
Temazepam - - - - + + + + - - + + - - - - - - - - 
THCA - - - - - - - - - - - - - - - - - - - - 
Tramadol - - - - - - - - - - - - - - - - - - - - 
DS: dilute and shoot. Tip: VAMS tip.  
Italicized drugs are released from the body as glucuronides. A positive result is denoted by +. A negative result is denoted by -.  




Initially, the linearity of the calibration curve for DS and VAMS had been set to be the same. 
Upon review the linearity equation for line of best fit for the DS technique is not the same as the 
equation for line of best fit for VAMS. Table 13 depicts the line fit, weighting, and R2 value for 




Table 13. Line fit, weighting, and R2 for calibration curve line of best fit for DS and VAMS. 
Analytes 
DS VAMS 
Line Fit Weighting R2 Line Fit Weighting R2 
6-MAM Linear 1/C^2 0.9984 Quadratic 1/C^2 0.9984 
Alpha-Hydroxyalprazolam Linear 1/C 0.9981 Quadratic 1/C 0.9975 
Amphetamine Linear 1/C 0.9954 Quadratic 1/C 0.9997 
Benzoylecgonine Linear 1/C 0.9971 Quadratic 1/C 0.9993 
Clonazepam Linear 1/C^2 0.9972 Quadratic 1/C 0.9990 
Codeine Linear 1/C^2 0.9960 Quadratic 1/C 0.9994 
Diazepam Linear 1/C 0.9956 Quadratic 1/C 0.9983 
Gabapentin Linear 1/C^2 0.9979 Quadratic 1/C 0.9997 
Hydrocodone Linear 1/C^2 0.9943 Quadratic 1/C^2 0.9996 
Hydromorphone Linear 1/C^2 0.9967 Quadratic 1/C^2 0.9983 
Lorazepam Linear 1/C^2 0.9978 Quadratic 1/C 0.9999 
Morphine Linear 1/C^2 0.9956 Quadratic 1/C 1.0000 
Norbuprenorphine Linear 1/C^2 0.9974 Quadratic 1/C 0.9996 
Nordiazepam Linear 1/C^2 0.9965 Quadratic 1/C 0.9992 
Norhydrocodone Linear 1/C^2 0.9972 Quadratic 1/C 0.9983 
Noroxycodone Linear 1/C^2 0.9929 Quadratic 1/C 0.9999 
Oxazepam Linear 1/C^2 0.9977 Quadratic 1/C 0.9984 
Oxycodone Linear 1/C^2 0.9959 Quadratic 1/C 0.9996 
Oxymorphone Linear 1/C 0.9963 Quadratic 1/C 0.9986 
Temazepam Linear 1/C^2 0.9975 Quadratic 1/C^2 0.9982 
THCA* Quadratic 1/C^2 0.9844 Quadratic 1/C^2 0.9878 
Tramadol Linear 1/C^2 0.9966 Quadratic 1/C 0.9981 
* THCA DS calibration curve did not include 20 and 50 ng/mL, lower limit was 150 ng/mL. 
 
4.6 Cost Analysis 
4.6.1 Specimens 
Specimen cups that hold 4 ounces of sample are available through many retailers. For 
instances, Fisher Scientific offers 100 specimen cups for approximately $32.00.45 The cost would 
calculate to be $0.32 per cup. This does not include product provider shipping costs. Mitra ® 
volumetric absorptive microsampling (VAMS) devices are only available from Neoteryx. 
According to a quotation from Neoteryx, a 6 pack of 96-rack 20 µL tips costs $1,625.00.46 This 
cost would calculate to be approximately $2.82 per tip. This cost does not include shipping cost 
from the retailer. 
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4.6.2 Shipping  
In the event the samples need to be shipped from one location to another there will be 
secondary shipping costs. Many shipping companies offer a type of flat rate shipment for 
different box sizes they provide. For example, FedEx offers a FedEX® Small Box at the size of 
8-3⁄4 × 2-5⁄8 × 11-1⁄4-in with flat rate shipping for packages under 50 lbs based on the distance 
between the two locations.47 Cost for shipping this small box ranges from $8.65 when 150 miles 
or less, up to $13.75 when traveling 601 miles or more.47 A 96-rack of VAMS tips would easily 
fit inside this box with some extra padding. 
While there are larger boxes available that could hold 96 specimen cups, the wet samples 
should be shipped cold. FedEx offers a variety of boxes that have a 48 or 96 hour cooling time at 
2-8°C.48 The exact sizes of specimen cups vary based on manufacturer. However, for this purpose 
it will be assumed the size is 3 × 3-in. A single layer of 96 specimen cups would best be laid out 
to be 12 rows with 8 cups each. This would require a box with an interior size of 36 × 24 × 3-in. 
Unfortunately, FedEx does not have a cool shipping box with those inner dimensions. Instead, 2 
layers of 6 rows by 8 cups would require a box with inner dimensions of 18 × 24 × 6-in. Once 
again, this size is not available through FedEx. The largest size cool shipping box FedEx has 
inner dimensions of 9.5 × 8.7 × 4.8-in, priced at $133.00 for 48 hours of cooling time.48 
Therefore, it would be necessary to ship multiple boxes. Each of these large boxes would be able 
to transport a single layer of 3 × 2 specimen cups. This would mean shipping only 6 samples per 
box, shipping 16 boxes to transport all 96 samples. Cost for the boxes alone would be $2,128.00. 








5.1 Glucuronide Conjugate Mix 
Based on the concentrations of the glucuronide conjugates determined in LC-MS/MS 
analysis, the recovery rate of each glucuronide was able to be calculated. Through statistical 
analysis, it was revealed there is a significant difference in the mean percent efficiency of the 
glucuronide recoveries using dilute and shoot (DS) and VAMS tips. Morphine (p-value: 0.226), 
THCA (p-value: 0.0127), lorazepam (p-value: 0.0030), oxazepam (p-value: 0.0033), and codeine 
(p-value: ≤ 0.001) were all found to be significantly different.  
It is important to keep in mind, that while the extraction processes were different, the β-
glucuronidase enzyme used in the two extraction processes were also different. DS used 
Campbell’s with a buffer solution prepared in-house, while VAMS used IMCSzyme and rapid 
hydrolysis buffer, which is a buffer obtained through IMCS intended to be used with their 
enzyme. As a result of the two extraction methods using two different enzymes, the statistically 
significant differences cannot be directly attributed to the extraction methods alone. Future 
research may be of interest to determine exactly which aspect, extraction method or enzyme, may 
be credited for the difference. 
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5.2 Volume Evaluation 
The DS and VAMS tips extraction processes called for the use of two different volumes 
of sample. DS was to use 50 µL, to be obtained using a calibrated pipet. Microsampling was to 
use 20 µL, to be obtained using a 20 µL Neoteryx Mitra ® VAMS device. A test was conducted 
to evaluate just how much sample was being used in each of the techniques. It was determined the 
volume of water and urine drawn up by the pipet was not significantly different than the expected 
50 µL. This was not the case for the VAMS tip. While there was no significant difference 
between the volume of deionized water and UTAK urine absorbed by the tip, there was a 
significant difference in the amount the tip actually absorbed versus the expected 20 µL. In the 
case of deionized water, absorbing on average 25.6 µL, there was a p-value of 0.0031, indicating 
a significant difference. While UTAK urine, absorbing on average 27.2 µL, there was a p-value 
less than 0.0001, also indicating a significant difference. To absorb the intended 20 µL of 
solution, the time in which the VAMS tip is in contact with the solution would need to be 
lessened from the manufacturer’s recommended 6 seconds.  
5.3 Internal Standard Comparison 
The concentration of a drug will be affected by the area of the internal standard (IS) 
associated with that particular drug. It was observed that DS had a greater IS area for 10 of the 11 
ISs used in the method. THCA-D3 was the only IS that had a greater area associated with it in the 
VAMS extraction technique. Preferential absorption of ISs are evident, however the reason for 






5.4 Unknown Samples 
LC-MS/MS allowed for the qualification and quantitation in the 10 unknown samples 
that were used in both extraction techniques.  As a whole, both techniques qualitatively identified 
the same drugs in each of the unknown samples. However, in 2 particular instances, there was a 
discrepancy in whether the unknown sample was positive or negative for an analyte. This was 
seen with Unknown 1 for hydrocodone and Unknown 3 with nordiazepam. While the analyte was 
able to be detected, the concentration fell below the lower limit of quantitation. In both instances, 
it was the DS extraction that was unable to be reported as positive for the drug.  
Unknown 10 was positive for gabapentin using both extraction techniques. However, in 
the DS technique, the gabapentin was saturated to the point that the computer program used for 
analysis was not able to estimate a concentration. As the goal of the unknown samples study was 
to determine if the same drugs were able to be qualitatively identified, gabapentin is considered 
positive in Unknown 10 DS. 
5.5 Linearity 
It was observed that the line of best fit for the calibration curve is not the same for the DS and 
VAMS extraction techniques. Each facility should conduct their own linearity study to determine 
what line fit and weighting provides the best fit line. 
5.6 Cost Analysis 
A single specimen cup is approximately $2.50 cheaper than a single VAMS tip. At first 
glance, specimen cups seem like the cheaper option. However, in terms of shipping the samples 
from one facility to another, dried VAMS are well over $2,000.00 less than wet specimen cup 
samples. Keeping the substantial price difference in mind, facilities would need to consider if 
there is a need for shipping specimens from one place to another. If there is that need, the 
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question of how many samples would be shipped at a time should be addressed at each facility 
when considering switching from wet specimen cup samples to dried VAMS tips.  
5.7 Comparisons to Other Research 
This study looked to compared glucuronide drug recovery and qualitative detection of drugs 
in the benzodiazepine class, opioid class, and 3 other miscellaneous drugs. At the time of this 
study there was one publication about VAMS urine testing by Mercolini et al. While Mercolini et 
al’s study compared wet and dry urine samples, the study only evaluated cathinones. At the time 
of writing, a second study using VAMS for urine was published by Protti et al. Protti et al’s study 
focused only on oxycodone and its 2 major metabolites. While all studies compared wet DS to 
dried VAMS, there are several key differences between the 3 studies. The OSU study used β-
glucuronidase enzyme, while the others did not, and the research completed at OSU included a 
wider variety of drugs than the other studies. Additionally, Mercolini et al. and Protti et al. set out 
to quantitate drug levels in the urine samples. The OSU research only did a quantitative analysis 
of glucuronide recovery. The goal of the unknown sample testing in the OSU study was 
qualitative in nature. However, all 3 studies demonstrated proof of concept for the use of VAMS 
tips for analysis of drugs in urine samples. 
5.8 Future Research 
Additional research should be conducted to determine the viability of VAMS for drug testing 
urine samples, especially if the hope is to replace wet DS and dried urine samples with VAMS. 
One such study should focus on altering the amount of time the VAMS tip is in contact with the 
urine to absorb the intended volume. It should be evaluated how samples of different 
consistencies are absorbed by the tip because the viscosity of urine is not identical for samples. It 
may also be possible for the VAMS device companies to include a dye to indicate adequate 
absorption of specimen at the appropriate volume. 
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The stability of urine samples on VAMS tips have not been studied in length. It is important 
to know how to maintain the integrity of the sample and ensure there is no drug degradation. 
Typically, validation studies have shown that wet samples are good for 3 days when stored in a 
refrigerator and good for a month when stored in a freezer. VAMS samples dry at room 
temperature, but the length of time they can be stored at room temperature is unknown, along 
with the appropriate storage conditions. It is important to know the answer to these questions 
before converting over to dried urine VAMS testing in a facility. 
Another study should look to compare the recovery of glucuronides by trying different β-
glucuronidase enzymes. This study used Campbell’s for DS and IMCS for VAMS.  The reason 
this study used Campbell’s for DS was because that was the type of enzyme used in the already 
validated method. IMCS had been used for VAMS based on literature review and other research 
at OSU has identified this enzyme as being very effective at hydrolyzing the analytes of interest 
in this method. 
Regular microcentrifuge tubes and tips were used throughout the research. It is possible that 
low binding tubes and tips will have “a bonded polymer technology that reduces protein and 
nucleic acid binding, resulting in better sample recovery.”49 It would be interesting to see if using 
low binding tubes and tips could potentially decrease any drug loss that is occurring. 
5.9 Discussion 
When initially doing the literature review, Volumetric Absorptive Microsampling (VAMS) 
appeared to be a promising alternative to wet urine drug testing. However, after completing 
research there are several elements that must be considered. While the research conducted at OSU 
and by other researchers have indeed proved VAMS is a viable option for dried urine drug 
testing, the technique does have some shortcomings. At this time, the volume of sample being 
absorbed by the tip is higher than expected. This runs the potential of having inconsistent 
volumes of sample absorbed. The viscosity of urine samples received in labs varies from the ideal 
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mostly water urine sample to highly turbid urine sample. It is unclear how the fluid viscosity 
factors in to the volume of sample absorbed by the tip.  
Furthermore, there are several ways in which a sample could be collected incorrectly using 
VAMS tips. The most obvious mistake being fully submerging the tip into the urine sample, 
which will retain more urine. Next is the potential for holding the tip to the surface for too short 
or too long of a time, affecting how much sample is absorbed. Employees need to be properly 
trained on how to collect samples using VAMS. As part of their training, employees would also 
need to understand how to ensure there is no sample contamination. The contamination could be 
cross sample contamination, mislabeling the tip, improper drying, contact with other 
chemicals/samples, and other factors. 
With VAMS, one tip goes to one specimen. However, in the event there is an error in the 
extraction process, there needs to be an additional sample available for repeat analysis. To 
circumvent this problem, at least 2 samples should be collected per specimen. That would mean 
that the cost per specimen will double, instead of $2.82 it would be $5.64 per specimen. This may 
not be an option financially for some laboratories. On the other hand, the dilute and shoot (DS) 
technique allows the laboratory technician to return to the wet specimen cup sample and re-
extract the sample, provided it has been properly stored to prevent drug degradation.  
While studies still need to be conducted to truly determine how to best store VAMS, at this 
time it is believe they would be able to be shipped in a regular, non-temperature controlled 
package. The size and cost of shipping a 96-tip rack would be much less than that of 96 specimen 
cups in cold storage. In the event there is no need to ship, then this would be a null point. For 
some labs, the number of samples they ship at a time may not be worth the cost of switching over 





This study set out to evaluate a wider range of drug classes than had been researched 
previously. From this research, proof has been supplied that VAMS is able to obtain valuable 
results through analysis. DS and VAMS both recovered glucuronides in the glucuronide 
experiment but VAMS had a higher recovery rate. When it came to unknown samples, both 
extraction techniques identified the same drugs. Findings of the research suggest VAMS has a 
higher sensitivity than that of DS. For the unknown samples, hydrocodone and nordiazepam were 
qualified below the lower limit of quantitation for DS, but were found to be above the lower limit 
of quantitation for VAMS. Additionally, the VAMS calibration curve was able to extend as low 
as 20 ng/mL in the case of (-)-11-nor-9-Carboxy-delta9-THC (THCA), whereas DS had a lower 
limit at 150 ng/mL. From the findings of this research, VAMS has demonstrated to be a viable 
option for dried urine drug testing of the drugs in the research panel. That being said, the decision 
to switch from a DS approach to a VAMS approach is something each laboratory needs to 
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